<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57-marinedrugs-18-00228">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hong</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Baran</surname>
    <given-names>J.T.</given-names>
   </name>
   <name>
    <surname>Allendorf</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Hansen</surname>
    <given-names>R.D.</given-names>
   </name>
   <name>
    <surname>Ostroff</surname>
    <given-names>G.R.</given-names>
   </name>
   <name>
    <surname>Xing</surname>
    <given-names>P.X.</given-names>
   </name>
   <name>
    <surname>Cheung</surname>
    <given-names>N.K.</given-names>
   </name>
   <name>
    <surname>Ross</surname>
    <given-names>G.D.</given-names>
   </name>
  </person-group>
  <article-title>Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models</article-title>
  <source>J. Immunol.</source>
  <year>2004</year>
  <volume>173</volume>
  <fpage>797</fpage>
  <lpage>806</lpage>
  <pub-id pub-id-type="doi">10.4049/jimmunol.173.2.797</pub-id>
  <pub-id pub-id-type="pmid">15240666</pub-id>
 </element-citation>
</ref>
